Vaccines are medicines that train the body to defend itself against future disease, and they have been saving human lives for hundreds of years. Vaccines are medicines that train the body to defend itself against future disease.
A.M. Edition for April 26. WSJ’s Chip Cutter on vaccine requirements among some employers. The U.S. offers aid to India as its Covid-19 cases skyrocket.
WSJ’s Quentin Webb looks at which nations will lead the economic recovery from the pandemic. This year’s Oscar winners. Marc Stewart hosts.
Chinese Covid-19 vaccines offer relatively low levels of protection compared with some of their foreign rivals. Here is why China is joining other countries in considering mixing and matching vaccines as a key to overcoming multiple vaccination challenges at once. Illustration: Ksenia Shaikhutdinova
A.M. Edition for April 21. WSJ reporters discuss reactions as former Minneapolis police officer Derek Chauvin is found guilty in the death of George Floyd.
WSJ’s Sabrina Siddiqui on vaccination challenges in the U.S. And, a soccer league meltdown in Europe. Marc Stewart hosts.
Remember the first COVID-19 vaccine jabs? They gave us hope that life might return to what it was before the pandemic. If we could only get enough people vaccinated. But some of the nations leading the world in vaccinations are still struggling with the coronavirus.
Lawmakers are beginning to dig in to President Biden’s $2 trillion infrastructure proposal while Democrats consider going it alone. More testimony from experts in use of force as the murder trial of former Minneapolis Officer Derek Chauvin continues.
And, some experts are worried that vaccine hesitancy and refusal could be high enough to prolong the pandemic.
From a sore arm to anaphylaxis, a wide range of adverse events have been reported after people have received a COVID-19 vaccine. And yet it is unclear how many of these events are actually caused by the vaccine. In the vast majority of cases, reactions are mild and can be explained by the body’s own immune response.
But monitoring systems designed to track adverse events are catching much rarer but more serious events. Now scientists need to work out if they are causally liked to the vaccine, or are just statistical anomalies – and that is not an easy task.News: Why is it so hard to investigate the rare side effects of COVID vaccines?Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
We get the latest from Brussels after the EU’s medicines regulator says the Astrazeneca vaccine is “safe and effective”.
Plus: we unpack the wave of anti-Asian attacks in the US and get the business headlines.